Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

969 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).
Wirth A, Prince HM, Roos D, Gibson J, O'Brien P, Zannino D, Khodr B, Stone JM, Davis S, Hertzberg M. Wirth A, et al. Among authors: roos d. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1158-1166. doi: 10.1016/j.ijrobp.2018.12.006. Epub 2018 Dec 13. Int J Radiat Oncol Biol Phys. 2019. PMID: 30553941
Prospective Phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02/ALLG NHL15.
MacManus MP, Roos D, O'Brien P, Capp A, Wirth A, Tsang R, Bressel M, Lade S, Seymour JF. MacManus MP, et al. Among authors: roos d. Eur J Cancer. 2021 Jul;152:129-138. doi: 10.1016/j.ejca.2021.05.004. Epub 2021 Jun 5. Eur J Cancer. 2021. PMID: 34098462 Clinical Trial.
Limited chemotherapy and shrinking field radiotherapy for Osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trial.
Christie D, Dear K, Le T, Barton M, Wirth A, Porter D, Roos D, Pratt G. Christie D, et al. Among authors: roos d. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1164-70. doi: 10.1016/j.ijrobp.2010.03.036. Epub 2010 Jul 16. Int J Radiat Oncol Biol Phys. 2011. PMID: 20638196 Clinical Trial.
Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group.
Wirth A, Grigg A, Wolf M, Goldstein D, Johnson C, Davis S, Dutu G, Kypreos P, Smith C, Kneebone A, Herzberg M, Joseph D, Catalano J, Roos D, Stone J, Reynolds J. Wirth A, et al. Among authors: roos d. Leuk Lymphoma. 2011 May;52(5):786-95. doi: 10.3109/10428194.2010.547155. Epub 2011 Feb 14. Leuk Lymphoma. 2011. PMID: 21314490 Clinical Trial.
Radiotherapy for bone metastases.
Hoskin PJ, Yarnold JR, Roos DR, Bentzen S; Second Workshop on Palliative Radiotherapy and Symptom Control. Hoskin PJ, et al. Among authors: roos dr. Clin Oncol (R Coll Radiol). 2001;13(2):88-90. doi: 10.1053/clon.2001.9225. Clin Oncol (R Coll Radiol). 2001. PMID: 11373885 Review. No abstract available.
Genotype-Phenotype Correlations in Chronic Granulomatous Disease: Insights From a Large National Cohort.
Wolach B, Gavrieli R, Wolach O, Salamon P Mrs, Boer M, van Leeuwen K, Abuzaitoun O, Broides A, Gottesman G, Grisaru-Soen G, Hagin D, Marcus N, Rottem M, Schlesinger Y, Stauber T, Stepensky P, Schejter Y, Zeeli T, Hanna S, Etzioni A, Frizinsky S, Somech R, Roos D, Lachover Roth I. Wolach B, et al. Among authors: roos d. Blood. 2024 Jun 21:blood.2023022590. doi: 10.1182/blood.2023022590. Online ahead of print. Blood. 2024. PMID: 38905634
969 results